Participants
“Having attended for the first time, we quickly realized how valuable the Biopharma Sustainability Roundtable was. We found it highly relevant, with discussions that provided valuable information on topics we are working on right now. The open exchange with our peers helped us to better understand opportunities and challenges in pursuing our sustainability work.”
Biopharma Members
Biopharma Sustainability Roundtable participation includes a wide range of companies, represented by senior level executives with strategic and operational responsibility for Sustainability, Corporate Responsibility, or ESG.
Past Participants
(acquired by AstraZeneca)
(acquired by BMS)
(acquired by AstraZeneca)
(Part of Merck KGaA)
(acquired by Takeda)
Other Stakeholders
The Biopharma Sustainability Roundtable hosts expert organizations and key sector stakeholders and facilitates conversations with a focus on the sector and its sustainability agenda.
Guests have included representatives from expert organizations such as NGOs, Foundations, trade associations, etc. and from the capital markets, such as investors, raters, standard-setters, stock exchanges, etc.
Thank you to the organizations that have joined over the years:
- Access Accelerated
- Access to Medicines Foundation
- BIO
- BU School of Public Health
- British Standards Institute
- BSR Healthcare and Human Rights Forum
- BSR Healthcare Working Group
- Capitals Coalition
- CARB-X
- CDP
- CECP’s CEO Investor Forum
- DuPont
- ECO:FACT
- EcoVadis
- EFPIA
- EFRAG
- Future-Fit Foundation
- Gates Foundation
- GBI
- GE Healthcare
- Gibson Dunn
- GRI
- Harvard Business School
- Health Outcomes Observatory, H2O
- High Meadows Institute
- IFPMA
- IFPW
- Impact Management Project
- Impact-Weighted Accounts Project
- International Integrated Reporting Council
- ISSB/IFRS Foundation
- ISS ESG (oekom)
- MIT Sloan Sustainability Initiative
- MSCI
- NASDAQ CPH
- NYSE
- Oxford University Saïd Business School
- Paxus LLP
- PSCI
- Polecat
- Purple Strategies
- Quantis
- RepRisk
- Rockefeller Foundation
- SASB
- S&P Global
- ThermoFisher Scientific
- TISFD
- TNFD
- Sustainable Medicines Partnership
- SustainAbility (ERM)
- Sustainalyltics
- Swiss Re
- UN Global Compact
- US Green Building Council
- US Pharmacopeia
- Value Balancing Alliance
- Value Reporting Initiative
- WBCSD
- WifOR
- World Economic Forum
- Wharton Business School
- Yew Maker
The Biopharma Sustainability Conference is an annual two-day flagship event that gathers BSRT company participants in person, alternating between Europe and the United States each fall. The Conference focuses on key biopharma sustainability topics, featuring world-class speakers, insightful case studies, and expert panel discussions to drive industry progress.
The Biopharma Sustainability Investor Day takes place on the third day, bringing together biopharma participants and the BSRT Investor Network for direct, in-person dialogue focused on the biopharma sector’s sustainability initiatives and investor perspectives.
All BSRT discussions, including the peer-to-peer networks, take place under the Chatham House Rule and anyone taking part must always refrain from any discussion, activity or conduct that may infringe on any applicable competition law.